Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.

Håvik B, Le Hellard S, Rietschel M, Lybæk H, Djurovic S, Mattheisen M, Mühleisen TW, Degenhardt F, Priebe L, Maier W, Breuer R, Schulze TG, Agartz I, Melle I, Hansen T, Bramham CR, Nöthen MM, Stevens B, Werge T, Andreassen OA, Cichon S, Steen VM.

Biol Psychiatry. 2011 Jul 1;70(1):35-42. doi: 10.1016/j.biopsych.2011.01.030. Epub 2011 Mar 24.

PMID:
21439553
2.

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.

Le Hellard S, Mühleisen TW, Djurovic S, Fernø J, Ouriaghi Z, Mattheisen M, Vasilescu C, Raeder MB, Hansen T, Strohmaier J, Georgi A, Brockschmidt FF, Melle I, Nenadic I, Sauer H, Rietschel M, Nöthen MM, Werge T, Andreassen OA, Cichon S, Steen VM.

Mol Psychiatry. 2010 May;15(5):463-72. doi: 10.1038/mp.2008.110. Epub 2008 Oct 21.

PMID:
18936756
3.

Common sequence variants in the major histocompatibility complex region associate with cerebral ventricular size in schizophrenia.

Agartz I, Brown AA, Rimol LM, Hartberg CB, Dale AM, Melle I, Djurovic S, Andreassen OA.

Biol Psychiatry. 2011 Oct 1;70(7):696-8. doi: 10.1016/j.biopsych.2011.02.034. Epub 2011 Apr 22.

PMID:
21514568
4.

Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

Rose EJ, Morris DW, Hargreaves A, Fahey C, Greene C, Garavan H, Gill M, Corvin A, Donohoe G.

Am J Med Genet B Neuropsychiatr Genet. 2013 Sep;162B(6):530-7. doi: 10.1002/ajmg.b.32182. Epub 2013 Jul 10.

PMID:
23839771
5.

A genetic association study of CSMD1 and CSMD2 with cognitive function.

Athanasiu L, Giddaluru S, Fernandes C, Christoforou A, Reinvang I, Lundervold AJ, Nilsson LG, Kauppi K, Adolfsson R, Eriksson E, Sundet K, Djurovic S, Espeseth T, Nyberg L, Steen VM, Andreassen OA, Le Hellard S.

Brain Behav Immun. 2017 Mar;61:209-216. doi: 10.1016/j.bbi.2016.11.026. Epub 2016 Nov 25.

6.

Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.

Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A, Benseler F, Hannke K, Sperling S, Schwerdtfeger D, Thanhäuser I, Gerchen MF, Ghorbani M, Gutwinski S, Hilmes C, Leppert R, Ronnenberg A, Sowislo J, Stawicki S, Stödtke M, Szuszies C, Reim K, Riggert J, Eckstein F, Falkai P, Bickeböller H, Nave KA, Brose N, Ehrenreich H.

Arch Gen Psychiatry. 2010 Sep;67(9):879-88. doi: 10.1001/archgenpsychiatry.2010.107. Erratum in: Arch Gen Psychiatry. 2010 Oct;67(10):1077.

PMID:
20819981
7.

Testing for genetic association between the ZDHHC8 gene locus and susceptibility to schizophrenia: An integrated analysis of multiple datasets.

Xu M, St Clair D, He L.

Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1266-75. doi: 10.1002/ajmg.b.31096.

PMID:
20661937
8.

An association study between the dymeclin gene and schizophrenia in the Japanese population.

Yazaki S, Koga M, Ishiguro H, Inada T, Ujike H, Itokawa M, Otowa T, Watanabe Y, Someya T, Iwata N, Kunugi H, Ozaki N, Arinami T.

J Hum Genet. 2010 Sep;55(9):631-4. doi: 10.1038/jhg.2010.72. Epub 2010 Jun 17.

PMID:
20555340
9.

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Lung FW, Shu BC, Kao WT, Chen CN, Ku YC, Tzeng DS.

BMC Med Genet. 2009 Dec 29;10:147. doi: 10.1186/1471-2350-10-147.

10.

Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

Donohoe G, Walters J, Hargreaves A, Rose EJ, Morris DW, Fahey C, Bellini S, Cummins E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Owen MJ, Gill M, O'Donovan MC, Tropea D, Rujescu D, Corvin A.

Genes Brain Behav. 2013 Mar;12(2):203-9. doi: 10.1111/gbb.12016.

11.

Association study between the pericentrin (PCNT) gene and schizophrenia.

Numata S, Nakataki M, Iga J, Tanahashi T, Nakadoi Y, Ohi K, Hashimoto R, Takeda M, Itakura M, Ueno S, Ohmori T.

Neuromolecular Med. 2010 Sep;12(3):243-7. doi: 10.1007/s12017-009-8106-x. Epub 2009 Nov 24.

PMID:
19937158
12.

Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.

Drgonova J, Walther D, Singhal S, Johnson K, Kessler B, Troncoso J, Uhl GR.

PLoS One. 2015 Jul 14;10(7):e0120908. doi: 10.1371/journal.pone.0120908. eCollection 2015.

13.

An association study on polymorphisms in the PEA15, ENTPD4, and GAS2L1 genes and schizophrenia.

Saito A, Fujikura-Ouchi Y, Ito C, Matsuoka H, Shimoda K, Akiyama K.

Psychiatry Res. 2011 Jan 30;185(1-2):9-15. doi: 10.1016/j.psychres.2009.09.018. Epub 2010 May 26.

PMID:
20537721
14.

The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia.

Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Iwase M, Iike N, Azechi M, Ikezawa K, Takaya M, Takahashi H, Yamamori H, Okochi T, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Kazui H, Iwata N, Takeda M.

Am J Med Genet B Neuropsychiatr Genet. 2010 Dec 5;153B(8):1459-64. doi: 10.1002/ajmg.b.31123. Epub 2010 Oct 18.

PMID:
20957649
15.

ZDHHC8 as a candidate gene for schizophrenia: analysis of a putative functional intronic marker in case-control and family-based association studies.

Faul T, Gawlik M, Bauer M, Jung S, Pfuhlmann B, Jabs B, Knapp M, Stöber G.

BMC Psychiatry. 2005 Oct 14;5:35.

16.

Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis.

Kishi T, Okochi T, Tsunoka T, Okumura T, Kitajima T, Kawashima K, Yamanouchi Y, Kinoshita Y, Naitoh H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Ozaki N, Iwata N.

Psychiatry Res. 2011 Jan 30;185(1-2):20-6. doi: 10.1016/j.psychres.2010.06.003. Epub 2010 Jul 1.

PMID:
20594600
17.

Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.

Schanze D, Ekici AB, Gawlik M, Pfuhlmann B, Reis A, Stöber G.

Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):198-203. doi: 10.1002/ajmg.b.31156. Epub 2011 Jan 13.

PMID:
21302348
18.

Brain expressed microRNAs implicated in schizophrenia etiology.

Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, Hall H, Timm S, Wang AG, Werge T.

PLoS One. 2007 Sep 12;2(9):e873.

19.

Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE).

Djurovic S, Le Hellard S, Kähler AK, Jönsson EG, Agartz I, Steen VM, Hall H, Wang AG, Rasmussen HB, Melle I, Werge T, Andreassen OA.

Psychiatry Res. 2009 Aug 15;168(3):256-8. doi: 10.1016/j.psychres.2008.08.007. Epub 2009 Feb 15.

PMID:
19223264
20.

A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population.

Ito Y, Nakamura Y, Takahashi N, Saito S, Aleksic B, Iwata N, Inada T, Ozaki N.

Neurosci Lett. 2008 Jun 13;438(1):70-5. doi: 10.1016/j.neulet.2008.04.010. Epub 2008 Apr 9.

PMID:
18455306

Supplemental Content

Support Center